Why closing knowledge gaps matters for patients, healthcare and innovation. VIENNA–BUSINESS WIRE– Between 27 and 36 million1 people in Europe are living with a rare disease, yet only around six percent currently have access to an approved treatment2. Progress in diagnosis and treatment is often slowed by knowledge gaps, including the lack of clear, reliable, ... Continued
AOP Health on Rare Diseases: Information. Collaboration. Innovation.
